ESMO 2024: Focus on Breast Cancer
View informative breast cancer content, featuring an interview led by Dr. Karine Tawagi of the Two Onc Docs at ESMO 2024, which took place September 13-17 in Barcelona, Spain.
Imaging modalities show significant efficacy in identifying metastasis among asymptomatic early-stage breast cancer.
Dr. Wungki Park gives an overview of the POLAR study for metastatic pancreatic cancer.
Dr. Wungki Park of Memorial Sloan Kettering Cancer Center discusses his trial on the use of ASP3082 for solid tumors.
Drs. Karine Tawagi and Adam Brufsky discuss exciting advancements and therapies on the horizon in the space of TNBC.
Dr. Adam Brufsky speaks with Dr. Adam Brufsky about the optimal therapeutic options to use in the TNBC patient population.
Drs. Karine Tawagi and Adam Brufsky discuss the biggest current challenges in the TNBC space.
A multimodal deep learning prediction model demonstrated notable prognostic and therapeutic predictive value in TNBC.
Advanced breast cancer in older patients is characterized by distinct molecular features.
Advertisement
Advertisement
© 2025 Mashup Media, LLC, a Formedics Property. All Rights Reserved.